UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 9, 2021
Accession Number:
Submission Type:
CIK:
0001537561
Company Name:
Arch Therapeutics, Inc.
File Number:
333-253588